THURSDAY | October 22, 2020 · e-Poster Presentation Session 1 Oncology & Theranostics PET Diagnostics - Part 1 13:30-15:00 15:00 - 15:10 15:00 - 15:10 15:10 - 16:25 201 Plenary 1

33rd Annual Congress of the European Association of Nuclear Medicine | October 22 - 30, 2020

O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L 3O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L2

L E T T E R O F I N V I T AT I O N

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

G

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

GT A B L E O F C O N T E N T S

Imprint 3Letter of Invitation by the Congress Chair 4EANM Board 6Scientific Programme Council 8

SCIENTIFIC & TECHNOLOGIST‘S PROGRAMME

» Programme Overview 10 » Session Descriptions 22 » Mid-Congress Symposia 24 » Plenary Sessions 26 » Continuing Medical Education/CME Sessions 28 » Joint Symposia 30 » EANM Young Daily Forum 32 » Pitfalls & Artefacts Sessions 33 » Teaching Sessions 34 » Cutting Edge Science Track 36 » M2M – The 7th “From Molecule to Man” Track 37 » Letter of Invitation by the Chair of the Technologist Committee 38 » Technologists‘ Track 40 » e-Poster area + On Demand Sessions 42 » Awards 43

EXHIBITION

» Industry Exhibition 45

REGISTRATION

» Fees 46

GENERAL INFORMATION 48

USEFUL CONTACTS 52

TA B L E O F C O N T E N T S

PUBLISHER European Association of Nuclear Medicine Schmalzhofgasse 26, 1060 Vienna, Austria Phone: +43 1 890 44 27 Fax: +43 1 890 44 27-9 Email: [email protected] Web: www.eanm.org

EDITORS Stefano Fanti, EANM Congress Chair 2020-2022 Andreas Felser, Susanne Koebe, EANM Executive Office

CONTENT No responsibility is taken for the correctness of this information. Information as per time of publication, March 2020.

LAYOUT & DESIGN Olga Dogadina, EANM Executive Office

I M P R I N T


EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

G

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

GL E T T E R O F I N V I T AT I O NL E T T E R O F I N V I T AT I O N

On behalf of the European Association of Nuclear Medicine, it is my great honour to invite you to the 33rd Annual EANM Congress, which will take place virtually from 22 to 30 October 2020.

Nuclear Medicine keeps on growing in many clinical areas, from diagnostic imaging to therapy: our procedures are increasingly being incorporated into clinical practice, in a variety of settings and diseases. This success is mostly related to a peculiar characteristic of our specialty, namely the functional approach to medicine. PET imaging works so well because of the unique functional information provided to clinicians, and this feature is the key to the ongoing rapid diffusion of Nuclear Medicine.

In recent years, the status of the EANM Congress as the world-leading meeting in Nuclear Medicine has been firmly established. The number of attendees in 2019 exceeded that in any previous year, with more than 6950 participants, but we are working to make the 2020 event even bigger, more memorable, and virtual.

EANM cares for its members, participants and patients, with safety being our primary concern as COVID-19 continues to pose a major health threat worldwide. Therefore, it was decided that it is in the best interest of the entire NM community to go virtual only.

The Virtual EANM Congress will still have all the features that made the event successful in the past. The usual excellent tracks and sessions, from CME to joint sessions, have already been confirmed. A

number of newer features are also being planned and we will have a new format for the plenary sessions, new top-rated oral presentation sessions and a new ‘Top Trials’ session.

A further characteristic of our Congress is its multidisciplinarity, and this will be emphasised in 2020, with a number of sessions bringing together physicians from many specialties as well as specialists in radiochemistry and pharmacy, physicists and other professionals. In addition, a dedicated track for technologists will be provided.

If all of this still isn’t enough to motivate you to attend the EANM’20 Congress virtually, we are working on providing some extra entertainment to make your virtual experience even more fun. This will include a daily nuclear quiz, daily programme highlights’ announcements, games and social opportunities.

Stefano FantiEANM Congress Chair 2020–2022

LETTER OFI N V I TAT I O Nby the Congress Chair

Stefano FantiCONGRESS CHAIR 2020-2022


EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

G

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

GB O A R DB O A R D

The Board is the highest executive level of the association, creating and safeguarding the EANM’s vision to help the specialty continue to thrive.Promoting scientific excellence is one of the corner stones of the EANM’s strategy that is proudly showcasted at the annual congress.

EANMBOARD

Wim OyenPRESIDENT 2019 - 2020

2

Jolanta KunikowskaPRESIDENT ELECT 2019 - 2020

Roland HustinxCOMMITTEE COORDINATOR 2019 - 2020

Stefano FantiCONGRESS CHAIR 2020 - 2022

Paola Anna ErbaEDUCATION CHAIR 2020 - 2022

Wolfgang WadsakSECRETARY/TREASURER 2019 - 2020

Michael LassmannSCIENTIFIC LIAISON OFFICER 2019 - 2020

98

S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP

RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0

E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G

SCIENTIFICPROGRAMMECO U N C I LC O N G R E S S C H A I R Stefano Fanti Italy

C O M M I T T E E R E P R E S E N TAT I V E C O U N T R Y

B O N E & J O I N T Salvatore Annunziata Italy

C A R D I O V A S C U L A R Fabien Hyafil France

D O S I M E T R Y Mark W. Konijnenberg Netherlands

D R U G D E V E L O P M E N T Johnny Vercouillie France

I N F L A M M AT I O N & I N F E C T I O N Giorgio Treglia Switzerland

N E U R O I M A G I N G Henryk Barthel Germany

O N C O L O G Y & T H E R A N O S T I C S Ken Herrmann Germany

PA E D I AT R I C S Pietro Zucchetta Italy

P H Y S I C S John Dickson United Kingdom

R A D I AT I O N P R O T E C T I O N Lídia Cunha Portugal

R A D I O P H A R M A C Y Peter Laverman Netherlands

T E C H N O L O G I S T Andrea Santos Portugal

T H Y R O I D Martha Hoffmann Austria

T R A N S L AT I O N A L M O L E C U L A R Fijs van Leeuwen NetherlandsI M A G I N G A N D T H E R A P Y

1110


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


Time (CEST) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CEST)

13:00 - 13:25

Welcome and Practical Info - A Virtual Introduction

13:00 - 13:25

13:25 - 13:30

13:25 - 13:30

13:30-15:00

101

CME 1Translational Molecular Imaging and Therapy +

Oncology & Theranostics Committee

Radar on Gynaecological Cancers

102

Joint Symposium 1Drug Development Committee / EFMC

Imaging Neuroinflammation

103

Joint Symposium 2TMIT + Drug

Development + Radiopharmacy +

Oncology & Theranostics Committee / WMISNano- and Micro-

Particles in Nuclear Medicine (Incl.

Radioembolisation)

104

Technologists‘ Opening (13:30-13:40)

CTE 1(13:40-15:00)

Technologist CommitteeTech Guide Launch

105

M2M Track TROP SessionRadiopharmacy +

Translational Molecular Imaging and Therapy

Committee

Translational Oncology Imaging

106

Cutting Edge Science Track TROP Session

Physics Committee

Quantification

107

Pitfalls & Artefacts 1

Neuroimaging Committee

Unexpected Findings in Brain Imaging

108

Clinical Oncology Track

Featured Session Oncology & Theranostics

Committee

Prostate Beyond Staging and Restaging

109

TROP SessionThyroid

Committee

Therapeutic Options in Thyroid

Cancer - Radioiodine and Beyond

110

Featured SessionCardiovascular

Committee

Advances in PET-MPI / CT

111

e-Poster Presentation

Session 1Oncology & Theranostics

Committee

PET Diagnostics - Part 1

13:30-15:00

15:00 - 15:10

15:00 - 15:10

15:10 -16:25

201

Plenary 1 incl. Marie Curie

Lecture

Total Body PET

15:10 -16:25

16:25 - 16:35

16:25 - 16:35

16:35 -18:05

301

CME 2Neuroimaging + Physics

Committee

Software Tools and Approaches to Measure

Nuclear Brain Images

302

Joint Symposium 3Oncology & Theranostics

Committee / EAU

Primary Staging of Prostate Cancer

Reloaded

303

Joint Symposium 4Radiation Protection

Committee / EURADOS

Hot Topics in Radiation Protection

304

CTE 2Technologist +

Paediatrics Committee

Update in Paediatric Imaging

305



CommitteeCardiology

Translational

306

Cutting Edge Science TrackTROP Session

Dosimetry Committee

Preclinical Dosimetry and Radiobiology

307


Thyroid Committee

Pre- and Post Therapeutic Imaging in

Thyroid Cancer

308


TROP SessionOncology & Theranostics

Committee

Interventional Nuclear Medicine - Local

Interventions

309

TROP Session/Featured Session

310

TROP Session/Featured Session

311



Committee

PET Diagnostics - Part 2

16:35 -18:05

18:05 - 18:10

18:05 - 18:10

18:10 - 19:00

Virtual Congress Opening

18:10 - 19:00

19:00 - 20:00 Welcome Social Hour

19:00 - 20:00

THURSDAY | O c t o b e r 2 2 , 2 0 2 0

Plenary Sessions CME Sessions Joint/Special Symposia Technologist Track M2M Track Cutting Edge Science Track Pitfalls & Artefacts / Teaching Sessions Clinical Oncology Track Mid-Congress-Symposia Further TROP/Featured Sessions e-Poster Presentation Sessions Special Sessions

1312


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


F R I D A Y | O c t o b e r 2 3 , 2 0 2 0Time (CEST) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CEST)

08:30-08:45 Nuclear Quiz

08:30-08:45

08:45-08:55 Daily Highlights

08:45-08:55

08:55-09:00

08:55-09:00

09:00 - 10:30

401

CME 3Radiopharmacy +

Oncology & Theranostics + Translational Molecular

Imaging and Therapy Committee

Finding the Right PET Companion for ImmunoOncology

402


Committee / EHA

Use of PET in Multiple Myeloma

403

Joint Symposium 6Cardiovascular

Committee / ASNC

Detecting Cardiac Toxicity of Cancer

Therapies with Nuclear Imaging

404a

Mini Course 1 (09:00 - 09:50)

Technologist CommitteeNew Developments in Cardiac Imaging

Instrumentation

404b

Mini Course 2 (10:00 - 10:50)

Technologist CommitteeAdvanced Practice in Hybrid Nuclear

Medicine

404c

Mini Course 3(11:00 - 11:50)

Technologist CommitteeAlpha Emitters in

Therapy

405



CommitteePharmacokinetics and

Chelators - Best of Both Worlds

406

Cutting Edge Science Track

Featured SessionRadiation Protection

Committee

Patient Radiation Protection

407

Teaching Session 1

TMIT + Physics Committee / EARL

Quantification and Standardisation in

Clinical and Preclinical Molecular Imaging

408


Featured Session Oncology & Theranostics

Committee

PRRT for NETs

409

TROP SessionNeuroimaging

Committee

Molecular Imaging of Movement Disorders

410

Featured SessionBone & Joint Committee

Molecular Bone Imaging - Nuclear

Medicine‘s Swiss Army Knife!

411


Session 3Dosimetry Committee

Clinical Dosimetry Methods

09:00 - 10:30

10:30 - 10:40

10:30 - 10:40

10:40 - 12:10

501

CME 4Bone & Joint Committee

Multimodality Imaging-Based Problem Solving

for Multiple Bone Lesions

502

Joint Symposium 7Neuroimaging Committee /

EAN / ECTRIMS

Multiple Sclerosis - Update in

Neuroimaging

503

Joint Symposium 8Radiopharmacy + Drug

Development Committee / SRS

The Revival of Radiometals

505

M2M Track TROP Session

Drug Development + Translational Molecular Imaging and Therapy

CommitteeIt Takes Place in the

Brain - New Neuro Tracers

506


Physics Committee

New Technologies and Imaging Techniques

507

Teaching Session 2

The Uncomfortable Truth - Are Nuclear

Medicine Physicians Viewed as Second Class

Doctors Compared to Radiologists?

508



Committee

PET for Haematological Tumours

509

Featured SessionThyroid

Committee

Parathyroid Imaging - Who

Scores the Best Goals in this Champions

League?

510



Committee

NET Diagnostics

511


Session 4Cardiovascular

Committee

The Best of Cardiovascular Imaging

in Short

10:40 - 12:10

12:10-12:15

12:10-12:15

12:15-13:45 Lunch Break

12:15-13:45

13:45-13:50

13:45-13:50

13:50 - 15:20

601

CME 5Oncology & Theranostics

Committee

Imaging Hepatobiliary and Pancreatic

Tumours - Pearls, Patterns and Pitfalls

602

Joint Symposium 9Inflammation & Infection

Committee / ESMI / ESCMID

Imaging Pulmonary Fungal Infections

603


Committee / JSNM

Nuclear Cardiology Beyond Perfusion

Imaging

604

Technologists Oral Presentations 1 - Featured Session

MATTER - MultidisciplinAry

TechnologisT rEseaRch

605

M2M Track Featured Session

Radiopharmacy + Translational Molecular Imaging and Therapy

Committee

Immune and Microenvironment

Imaging

606


Physics Committee

Image Processing - Neurology

607


Dosimetry Committee

Dosimetry as Part of Patient Care

608


Featured SessionOncology & Theranostics

CommitteeBCR Detection with Ga-

PSMA and Beyond

609

TROP SessionPaediatrics Committee

Nuclear Playground - Nuclear Medicine in Children

and Adolescents

610

Featured SessionNeuroimaging

Committee

Molecular Brain Tumour Imaging

611


Session 5Thyroid

Committee

The Thyroid and its Neighbours (The

Parathyroids)

13:50 - 15:20

15:20 -15:30

15:20 -15:30

15:30 -16:45

701

Plenary 2

Cardiac Nuclear Medicine -

Present and Future

15:30 -16:45

16:45-16:55

16:45-16:55

16:55 -18:25

801

CME 6Drug Development + Radiopharmacy + Neuroimaging

CommitteeBloody Hell!!! Impact

on Quantitation of Blood Radiotracer

Measurements

802


Committee / ESTRO

How Much PET does Radiation Oncology

Require?

803


Committee / EACVI

Selecting the Right Imaging for the Right

Patient in CAD

804

Technologists

Technologist e-Poster Presentation

Session 1

805


Radiopharmacy + TMIT + Oncology & Theranostics

Committee Translational

Interventional Nuclear Medicine

806


Radiation Protection Committee

Radiation Protection of Staff, and Advances in

Technology

807


Oncology & Theranostics + Inflammation & Infection

CommitteeInterpretation of

Response Monitoring During Immune

Therapy

808



Committee

Breast PET

809


Committee


810


Committee


811

Technologists

Technologist e-Poster Presentation

Session 2

16:55 -18:25

1514


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


Time (CEST) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CEST)

08:30-08:45 Nuclear Quiz

08:30-08:45

08:45-08:55 Daily Highlights

08:45-08:55

08:55 -09:00

08:55 -09:00

09:00 - 10:30

901

CME 7Inflammation & Infection + Paediatrics Committee

Nuclear Medicine in Paediatric Infections

902


Committee / EHA

Metabolic Tumour Volume (MTV) in

Lymphoma

903

Joint Symposium 14Drug Development

Committee / SRS

Transporter‘s Imaging

904

CTE 3Technologist + Dosimetry

Committee

Calibration for Instrumentation for

Dosimetry

905


Translational Molecular Imaging and Therapy +


Image Guided Treatment and Biopsy

906


Dosimetry Committee

Dosimetry Methods and Models - Part 1

907

Teaching Session 3

A Practical Guide to MR when Reading PET/MR

908



CommitteePET Diagnostics in

Head Neck Cancers and Melanoma

910

TROP SessionThyroid

Committee

Nuclear Endocrinology in Diagnosis and

Therapy

911


Session 6Physics

CommitteePhysics - Hardware and

Optimisation

09:00 - 10:30

10:30 -10:40

10:30 -10:40

10:40 -12:10

1001

CME 8Paediatrics Committee

Emergency Conditions in Paediatric Nuclear

Medicine

1002

Joint Symposium 15Thyroid Committee /

ETA-CG

Systemic Therapeutic Options in Advanced

Thyroid Cancer

1003

Joint Symposium 16Bone & Joint Committee

/ EACMFS

Role of Hybrid Imaging in Jaw and Skull

Conditions

1004

CTE 4 Technologist Committee

NET Imaging and Therapy

1005


Translational Molecular Imaging and

Therapy + Drug Development CommitteeNew Kids on the Block -

New Tracers

1006


Physics Committee

AI - Radiomics and Modelling

1007

Teaching Session 4

The Intellectual and Emotional Journey to

Radiology and Nuclear Equality

1008



CommitteeBest of Nuclear

Medicine Therapy

1009



CommitteeOnco Diagnostics

Miscellaneous

1010


Committee

Nuclear Imaging in Cardiac Arrhythmias

1011


Session 7Inflammation & Infection

CommitteeNuclear Medicine

for Infection & Inflammation - The

Story Continues

10:40 -12:10

Time (CET) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CET)

Free


09:30 -12:15

Mid-Congress- Symposium 1Cardiovascular +

Inflammation & Infection Committee / EACVI

Detecting Cardiac Amyloidosis -

Increasing Role of Nuclear Medicine

Mid-Congress- Symposium 2

Physics + Dosimetry Committee

Artificial Intelligence in Image Acquisition, Reconstruction and

Processing

09:30 -12:15

12:15 -12:20

12:15 -12:20

12:20 -13:50

EANM Young Daily Forum 1

Simply the Best – Presentation Skills for Medical Professionals

12:20 -13:50

13:50 -14:00

13:50 -14:00

14:00 -16:45


Oncology & Theranostics + Radiopharmacy + Drug Development Committee

/ ESMOClinical Development

of Radioligand Therapy


Translational Molecular Imaging and Therapy +


Image Guided Surgery

14:00 -16:45

S A T U R D A Y | O c t o b e r 2 4 , 2 0 2 0

S U N D A Y | O c t o b e r 2 5 , 2 0 2 0

M O N D A Y | O c t o b e r 2 6 , 2 0 2 0

1716


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0



09:30 -12:15



How to Read PET/CT - Different Shades of

Sugar (FDG)

Mid-Congress- Symposium 6Dosimetry + TMIT

+ Onco. & Theran. + Rad. Prot. + Infl. & Inf.

CommitteeImproved Insights into Radiobiology - Key for Radionuclide Therapy

09:30 -12:15

12:15 -12:20

12:15 -12:20

12:20 -13:50


I will survive - Managing Work Stress

and Building Your Resilience

12:20 -13:50

13:50 -14:00

13:50 -14:00

14:00 -16:45


Dosimetry + Oncology & Theranostics + Physics

CommitteeLutetium Therapy

Mid-Congress- Symposium 8For Youngsters -

Essential Oncology for Young Nuclear

Medicine Physicians

14:00 -16:45


09:00 -09:30


(09:00 - 16:00)

Technologist + Dosimetry + Physics Committee

Introduction to Dosimetry

09:00 -09:30

09:30 -12:15


Thyroid + Radiation Protection Committee /

ETA / ESES

Update on Treatment of Hyperthyroidism


Inflammation & Infection Committee

Diagnostic Flowcharts on Musculoskeletal

Infections

09:30 -12:15

12:15 -12:20

12:15 -12:20

12:20 -13:50


Nothing else matters - Get your paper

published in a top journal

12:20 -13:50

13:50 -14:00

13:50 -14:00

14:00 -16:45

Mid-Congress- Symposium 11Neuroimaging + Radiopharmacy

CommitteeCurrent State and Future of Tau PET

Imaging

Mid-Congress- Symposium 12For Youngsters -

Emergency During Nuclear Medicine

Procedures - What to Know and What to Do?

14:00 -16:45

T U E S D A Y | O c t o b e r 2 7 , 2 0 2 0

W E D N E S D A Y | O c t o b e r 2 8 , 2 0 2 0

1918


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0



13:00 -13:15 Nuclear Quiz

13:00 -13:15

13:15 -13:25 Daily Highlights

13:15 -13:25

13:25 - 13:30

13:25 - 13:30

13:30 -15:00

1101

CME 9Oncology & Theranostics +

Physics Committee

New PET Technologies - Digital

Revolution or Big Bust?

1102

Joint Symposium 17Drug Development Committee / EORTC

Benchside to Bedside and Back - What do we Learn from the Clinic?

1103


+ Inflammation & Infection Committee

/ AIO

Imaging Tumour Microenvironment

1104


TOP - Technologist Overview and Practice

impact

1105 1106


Dosimetry Committee

Dosimetry Methods and Models - Part 2

1107


Inflammation & Infection Committee

FDG-PET Performed or Suspicious for

Infections and Inflammation,

Including COVID-19

1108



Committee

Detecting BCR with [68Ga]Ga-PSMA

1109


Committee

Advances in SPECT-MPI

1110


Featured SessionPhysics

Committee

Radiomics

1111

13:30 -15:00

15:00 -15:10

15:00 - 15:10

15:10 - 16:25

1201

Plenary 3

What‘s Cooking? Next Generation

Radiopharmaceuticals

15:10 - 16:25

16:25 - 16:35

16:25 - 16:35

16:35 - 18:05

1301

CME 10 Thyroid

Committee

Radiomics in Thyroid Imaging

1302


Committee / ENETS

Impacting the Outcome of High Grade NET

Patients

1303

Joint Symposium 20Neuroimaging

Committee / ECNP

Simultaneous PET/MR Imaging of

Neuroreceptor Systems

1304


BOTH ART - The Beauty Of The HeART and mind

1305


Drug Development + Radiopharmacy

Committee

The Revival of Pre-Targeting

1306


Featured SessionPhysics

CommitteeIntra-Operative Nuclear

Medicine

1307


Paediatrics Committee

Pitfalls and Artefacts in Paediatric Nuclear

Medicine

1308



Committee

PET Diagnostics of Lung Cancer and

Mesothelioma

1309

Hot Topic Session

Best Clinical Trials

1309 1311



Committee

All About the Prostate - Staging, Restaging and

Beyond

16:35 - 18:05

T H U R S D A Y | O c t o b e r 2 9 , 2 0 2 0


2120


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0



08:30 -08:45 Nuclear Quiz

08:30 -08:45

08:45 -08:55 Daily Highlights

08:45 -08:55

08:55 -09:00

09:00 -10:30

1401

CME 11Oncology & Theranostics + Translational Molecular

Imaging and Therapy Committee

SLN - Past and Future

1402

Joint Symposium 21Drug Development +

Physics Committee / IEEE

Total Body PET Imaging

1403

Joint Symposium 22Paediatrics Committee /

ESPGHAN

Nuclear Medicine Techniques in the Evaluation of GI

Motility in Children

1404

CTE 5Technologist Committee

Departmental Organisation

1405



CommitteeNew and Established

Tracers - Prostate only!

1406


Dosimetry Committee

Dosimetry for PRRT and PSMA

1407

Teaching Session 5


PET/CT Guided Biopsy

1408



CommitteePET Diagnostics of

Gynaecological and GI Tumours

1409


CommitteeNuclear Imaging in Inflammatory and Infiltrative Cardiovascular

Diseases

1410

TROP Session

General Nuclear Medicine

1411


Session 9Physics

Committee

Physics - Software and Image Processing

09:00 -10:30

10:30 -10:40

10:30 -10:40

10:40 - 12:10

1501

CME 12Dosimetry Committee

Alpha Particle Therapy Without Imaging -

Options for Dosimetry, the Alpha and Omega

1502


Committee / ESDO

New Diagnostic and Therapeutic Frontiers in

Digestive Oncology

1503

Joint Symposium 24Physics + Paediatrics Committee / EFOMP

Technical Advances in Paediatric Dose

Reduction

1504

CTE 6 Technologist Committee

Advanced Competencies

1505

M2M Track Featured SessionTranslational Molecular Imaging and Therapy

+ Radiopharmacy Committee

Targeted Radionuclide Therapy - Trick or Treat?

1506


Physics Committee

Image Reconstruction and Corrections

1507

Teaching Session 6

Cardiovascular Committee

Difficult Cases in Cardiac Imaging

1508



CommitteeProstate Cancer Therapy - PSMA, 223Ra and More...

1509

TROP SessionThyroid

CommitteeIs It or Is It Not Malignant? -

Diagnostic/Predictive Options in Thyroid

Nodules

1510

TROP SessionInflammation & Infection

Committee

Our Army at War - Nuclear Medicine and

COVID-19

1511


Session 10Neuroimaging

Committee

Molecular Brain Imaging

10:40 - 12:10

12:10 -12:15

12:10 -12:15

12:15 -13:45 Lunch Break

12:15 -13:45

13:45 -13:50

13:45 -13:50

13:50 - 15:20

1601

CME 13Translational Molecular Imaging and Therapy + Physics + Oncology

& Theranostics + Technologist Committee

Radiomics in a Preclininical and a

Clinical Setting

1602

Joint Symposium 25Neuroimaging

Committee / EANO

Immunotherapy in Brain Tumours

1603

Joint Symposium 26Physics + Oncology &

Theranostics Committee / AAPM

Quantitative SPECT - An Essential Tool?

1605 1606


Physics Committee

Harmonisation & Standardisation

1607

Pitfalls & Artefacts 7Bone & Joint Committee

Bone SPECT/CT Revisited - Learning an

Old Fox New Tricks

1608



Committee

All About Staging the Prostate

1609

TROP SessionInflammation & Infection

Committee

PET for Infection and Inflammation - A New

Story

1610 1611



Committee

Nuclear Medicine Therapy Beyond

13:50 - 15:20

15:20 - 15:30

15:20 - 15:30

15:30 - 17:00

1701

CME 14Oncology & Theranostics

Committee

Molecular Drug Imaging of Solid

Tumours Including Microenvironment

1702

Joint Symposium 27TMIT + Oncology & Theranostics + Cardiovascular +

Inflammation & Infection Committee / ESMI

Radar on Immune Cell Imaging

1703

Joint Symposium 28Cardiovascular +

Translational Molecular Imaging and Therapy + Drug Development

Committee / AHANew Approaches for

Cardiovascular Imaging

1704

CTE 7

Technologist Committee

Quality Control of Imaging

Instrumentation

1705



CommitteeHot Stuff - Radionuclide

Production

1706


Physics Committee

AI - Image Processing and Data Corrections

1707

Teaching Session 7

Thyroid Committee

Molecular Imaging in Thyroid Nodules

1708



Committee

[177Lu]Lu-PSMA Radioligand Therapy

1709


Committee

Novel Molecular Brain Imaging Approaches

1710 1711



Committee

Onco Diagnostics - Mixed Bag

15:30 - 17:00

17:00 - 17:05

17:00 - 17:05

17:05 -18:25

1801

Honorary Member Award

Marie Curie Award

Plenary 4 - Highlights Lecture

Closing

17:05 -18:25


F R I D A Y | O c t o b e r 3 0 , 2 0 2 0

2322


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


PRESENTATION TYPESINVITED SPEAKERSInvited talks will be presented in different types of sessions (hereunder in alphabetical order):

CME Session: 90 minutes session, granting CME credits

CTE Session: 90 minutes session, part of the Technologist’s Track

Featured Session: 90 minutes session, invited speakers give an introduction talk on the topic, followed by accepted paper presentations

Joint Symposium: 90 minutes session, jointly organised in cooperation between EANM and its partner societies to provide a multidisciplinary approach

Mini Course: 60 minutes sessions, part of the Technologist’s Track

Pitfalls & Artefacts Session: 90 minutes session, presentation of clinical cases

Plenary Session: 75 minutes session with five or more speakers, being the most prestigious sessions of EANM, allowing everybody to join as no other sessions run in parallel

Mid-Congress Symposium: 180 minutes session incl. coffee break, on Saturday only. Additional CME credits will be granted. Extra charges apply

Mid-Congress Symposium Technologists: full day session incl. two coffee breaks, on Saturday only. Extra charges apply

Teaching Session: 90 minutes session, presentation of clinical cases

PRESENTATION TYPESACCEPTED ABSTRACTS WITH ORAL ONSITE PRESENTATION

PRESENTATION TYPESACCEPTED ABSTRACTS WITH NO ORAL PRESENTATION

Accepted papers of EANM´20 will be presented in different types of session formats (hereunder in alphabetical order):

e-Poster Presentation Session (EPP): Each paper will be presented as uploaded e-Poster in a 5 minutes slot

e-Poster Presentation Session Technologists (TEPP): Each paper will be presented as uploaded e-Poster in a 4 minutes slot

Featured Sessions: Invited speakers give an introduction talk on the topic, followed by accepted papers. Each paper will be presented by using powerpoint slides in a 7 minutes slot

Top Rated Oral Presentation (TROP) Session: Each paper will be presented by using powerpoint slides in a 7 minutes slot

e-Poster (only): Digital posters are uploaded as electronic poster to the e-Poster System. Those papers do not have an onsite presentation but are available throughout the congress in the e-Poster Area. Submitters can be contacted via email through the system.

2524


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


1 Monday, October 26, 09:30 – 12:15Detecting Cardiac Amyloidosis – Increasing Role of Nuclear MedicineCardiovascular + Inflammation & Infection Committee / EACVI

2 Monday, October 26, 09:30 – 12:15Artificial Intelligence in Image Acquisition, Reconstruction and ProcessingPhysics + Dosimetry Committee

3 Monday, October 26, 14:00 – 16:45Clinical Development of Radioligand TherapyOncology & Theranostics + Radiopharmacy + Drug Development Committee / ESMO

4 Monday, October 26, 14:00 – 16:45 Image Guided SurgeryTranslational Molecular Imaging & Therapy + Oncology & Theranostics Committee

5 Tuesday, October 27, 09:30 – 12:15How to Read PET/CT – Different Shades of Sugar (FDG)Oncology & Theranostics Committee

6 Tuesday, October 27, 09:30 – 12:15Improved Insights into Radiobiology – Key for Radionuclide TherapyDosimetry + TMIT + Onco. & Theran. + Rad. Prot. & Infl. + Inf. Committee

7 Tuesday, October 27, 14:00 – 16:45Lutetium TherapyDosimetry + Oncology & Theranostics + Physics Committee

8 Tuesday, October 27, 14:00 – 16:45For Youngsters – Essential Oncology for Young Nuclear Medicine Physicians

9 Wednesday, October 28, 09:30 – 12:15Update on Treatment of HyperthyroidismThyroid + Radiation Protection Committee / ETA / ESES

10 Wednesday, October 28, 09:30 – 12:15Diagnostic Flowcharts on Musculoskeletal InfectionsInflammation & Infection Committee

11 Wednesday, October 28, 14:00 – 16:45Current State and Future of Tau PET ImagingNeuroimaging + Radiopharmacy Committee

12 Wednesday, October 28, 14:00 – 16:45For Youngsters – Emergency During Nuclear Medicine Procedures – What to Know and What to Do?

13 Wednesday, October 28, 09:00 – 16:00Mid-Congress Symposium for Technologists - Introduction to DosimetryTechnologist + Dosimetry + Physics Committee

MID-CONGRESSS YM P O S I A

26

S C I E N T I F I C P R O G R A M M EP

RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


S C I E N T I F I C P R O G R A M M E

1 Thursday, October 22, 15:10 – 16:25Total Body PET (incl. Marie Curie Lecture)Chairpersons: Jolanta Kunikowska (PL), Michael Lassmann (DE), Dimitris Visvikis (FR)

» A Game Changer for the Future of PET, Dimitris Visvikis (FR)

» Marie Curie Lecture: Physics and Development of Total Body PET, Simon Cherry (US)

» Is Dynamic PET Imaging Ready for Prime Time?, Irene Buvat (FR)

» Drug Development and Evaluation with Total Body PET, Johannes Czernin (US)

» Scientific Opportunities and their Use, Bernd Pichler (DE)

» Challenge for Technologists, Andrea Santos (PT)

» A Must Have or Another Expensive Luxury Tool?, Ken Herrmann (DE)

» Discussion, All Speakers

2 Friday, October 23, 15:30 – 16:45 Cardiac Nuclear Medicine – Present and FutureChairpersons: Paola Anna Erba (IT ), Wanda Acampa (IT ), Hein Verberne (NL)

» Renew or Fade Away, Hein Verberne (NL)» Do we meet the Clinical Demand?, Wanda Acampa (IT)» MBF – Lost in Clinical Translation?, Ronny Büchel (CH)» Imaging Cardiac Amyloidosis, Sharmila Dorbala (US)

» Endocarditis, Paola Anna Erba (IT)


3 Friday, October 30, 15:10 – 16:25What’s Cooking? Next Generation RadiopharmaceuticalsChairpersons: Jane Sosabowski (UK), Melpomeni Fani (CH), Wolfgang Wadsak (AT)

» What’s New?, Melpomeni Fani (CH)

» FAP-Inhibitors are the Future – For Everything?, Uwe Haberkorn (DE)

» Brain Tracers – Finally for Clinical Application?, Valentina Garibotto (CH)

» Is Theranostics the Future in Nuclear Medicine?, Michael Hofman (AU)

» Do we need Specific Tracers in the Clinics?, Meltem Ocak (TR)

» Why does it take so long?, Jane Sosabowski (UK)


4 Friday, October 30, 17:12 – 18:12Highlights Lecture Moderators: Roland Hustinx (BE), Arturo Chiti (IT )

PLENARYSESSIONS

2928


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20


PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0

1 Thursday, October 22, 13:30 – 15:00Radar on Gynaecological CancersTranslational Molecular Imaging and Therapy + Oncology & Theranostics Committee

2 Thursday, October 22, 16:35 – 18:05 Software Tools and Approaches to Measure Nuclear Brain ImagesNeuroimaging + Physics Committee

3 Friday, October 23, 09:00 – 10:30Finding the Right PET Companion for ImmunoOncologyRadiopharmacy + Oncology & Theranostics + Translational Molecular Imaging and Therapy Committee

4 Friday, October 23, 10:40 – 12:10 Multimodality Imaging-Based Problem Solving for Multiple Bone LesionsBone & Joint Committee

5 Friday, October 23, 13:50 – 15:20Imaging Hepatobiliary and Pancreatic Tumours – Pearls, Patterns and PitfallsOncology & Theranostics Committee

6 Friday, October 23, 16:55 – 18:25Bloody Hell!!! Impact on Quantitation of Blood Radiotracer MeasurementsDrug Development + Radiopharmacy + Neuroimaging Committee

7 Saturday, October 24, 09:00 – 10:30Nuclear Medicine in Paediatric InfectionsInflammation & Infection + Paediatrics Committee

CMESESSIONS

8 Saturday, October 24, 10:40 – 12:10 Emergency Conditions in Paediatric Nuclear MedicinePaediatrics Committee

9 Thursday, October 29, 13:30 – 15:00 New PET Technologies – Digital Revolution or Big Bust?Oncology & Theranostics + Physics Committee

10 Thursday, October 29, 16:35 – 18:05Radiomics in Thyroid ImagingThyroid Committee

11 Friday, October 30, 09:00 – 10:30SLN – Past and FutureOncology & Theranostics + Translational Molecular Imaging and Therapy Committee

12 Friday, October 30, 10:40 – 12:10 Alpha Particle Therapy Without Imaging – Options for Dosimetry, the Alpha and OmegaDosimetry Committee

13 Friday, October 30, 13:50 – 15:20 Radiomics in a Preclininical and a Clinical SettingTranslational Molecular Imaging and Therapy + Physics + Oncology & Theranostics + Technologist Committee

14 Friday, October 30, 15:30 – 17:00Molecular Drug Imaging of Solid Tumours Including MicroenvironmentOncology & Theranostics Committee

Continuing Medical Education Sessions will span over five days of the EANM’20 Virtual Congress. The congress has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 31 European CME credits (ECMEC®s).

3130


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


1 Imaging NeuroinflammationDrug Development Committee / EFMC

2 Nano- and Micro-Particles in Nuclear Medicine (Incl. Radioembolisation) Translational Molecular Imaging and Therapy + Drug Development + Radiopharmacy + Oncology & Theranostics Committee / WMIS

3 Primary Staging of Prostate Cancer ReloadedOncology & Theranostics Committee / EAU

4 Hot Topics in Radiation ProtectionRadiation Protection Committee / EURADOS

5 Use of PET in Multiple MyelomaOncology & Theranostics Committee / EHA

6 Detecting Cardiac Toxicity of Cancer Therapies with Nuclear ImagingCardiovascular Committee / ASNC

7 Multiple Sclerosis – Update in NeuroimagingNeuroimaging Committee / EAN / ECTRIMS

8 The Revival of RadiometalsRadiopharmacy + Drug Development Committee / SRS

9 Imaging Pulmonary Fungal InfectionsInflammation & Infection Committee / ESMI / ESCMID

10 Nuclear Cardiology Beyond Perfusion ImagingCardiovascular Committee / JSNM

11 How Much PET does Radiation Oncology Require?Oncology & Theranostics Committee / ESTRO

12 Selecting the Right Imaging for the Right Patient in CADCardiovascular Committee / EACVI

13 Metabolic Tumour Volume (MTV) in LymphomaOncology & Theranostics Committee / EHA

14 Transporter’s ImagingDrug Development Committee / SRS

15 Systemic Therapeutic Options in Advanced Thyroid CancerThyroid Committee / ETA-CG

16 Role of Hybrid Imaging in Jaw and Skull ConditionsBone & Joint Committee / EACMFS

17 Benchside to Bedside and Back – What do we Learn from the Clinic?Drug Development Committee / EORTC

18 Imaging Tumour MicroenvironmentOncology & Theranostics + Inflammation & Infection Committee / AIO

19 Impacting the Outcome of High Grade NET PatientsOncology & Theranostics Committee / ENETS

20 Simultaneous PET/MR Imaging of Neuroreceptor SystemsNeuroimaging Committee / ECNP

21 Total Body PET ImagingDrug Development + Physics Committee / IEEE

22 Nuclear Medicine Techniques in the Evaluation of GI Motility in ChildrenPaediatrics Committee / ESPGHAN

23 New Diagnostic and Therapeutic Frontiers in Digestive OncologyOncology & Theranostics Committee / ESDO

24 Technical Advances in Paediatric Dose ReductionPhysics + Paediatrics Committee / EFOMP

25 Immunotherapy in Brain TumoursNeuroimaging Committee / EANO

26 Quantitative SPECT – An Essential Tool?Physics + Oncology & Theranostics Committee / AAPM

27 Radar on Immune Cell ImagingTranslational Molecular Imaging and Therapy + Oncology & Theranostics + Cardiovascular + Inflammation & Infection Committee / ESMI

28 New Approaches for Cardiovascular ImagingCardiovascular + Translational Molecular Imaging and Therapy + Drug Development Committee / AHA

JOINTSYMPOSIAEANM is again teaming up with its partner societies to fully reflect the multidisciplinarity of Nuclear Medicine.Find the list of Joint Symposia hereunder.

https://eanm20.eanm.org/programme/partner-societies/



























3332


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


The EANM Young Daily Forum is the ideal platform for all young talents attending the EANM congress – and those young at heart! It consists of a series of interactive lunch-time sessions open to all participants, particularly those who are at the beginning of their career.Each 1.5 hours’ time slot will focus on a different topic, two of them will be moderated in an interactive way by the professional facilitator Roy Sheppard. Participants will not only benefit from Roy’s vast experience as moderator and speaker, but will also have the opportunity to get to know new people in a relaxed atmosphere. The session on Wednesday will feature two highly experienced editors-in-chief, Arturo Chiti from the EJNMMI and Johannes Czernin from the JNM, as well as the former editor-in-chief of the EJNMMI and world-renowned nuclear medicine expert Ignasi Carriò from Spain. Participation is free for everyone registered to the EANM Annual Congress.

EANM YOUNGDAILY FORUM

1 Monday, October 2612:20 - 13:50

Simply the Best – Presentation Skills for Medical Professionals

2 Tuesday, October 2712:20 - 13:50

I will Survive - Managing Work Stress and Building Your Resilience

3 Wednesday, October 28

12:20 - 13:50

Nothing Else Matters - Get Your Paper Published in a Top Journal

1 Thursday, October 22, 13:30 – 15:00 Unexpected Findings in Brain ImagingNeuroimaging Committee

2 Thursday, October 22, 16:35 – 18:05 Pre- and Post Therapeutic Imaging in Thyroid CancerThyroid Committee

3 Friday, October 23, 13:50 – 15:20 Dosimetry as Part of Patient CareDosimetry Committee

4 Friday, October 23, 16:55 – 18:25 Interpretation of Response Monitoring During Immune TherapyOncology & Theranostics + Inflammation & Infection Committee

5 Thursday, October 29, 13:30 – 15:00FDG-PET Performed or Suspicious for Infections and Inflammation, Including COVID-19Inflammation & Infection Committee

6 Thursday, October 29, 16:35 – 18:05 Pitfalls and Artefacts in Paediatric Nuclear MedicinePaediatrics Committee

7 Friday, October 30, 13:50 – 15:20Bone SPECT/CT Revisited – Learning an Old Fox New TricksBone & Joint Committee

PITFALLS & ARTEFACTSSESSIONSThis year’s seven sessions will span over four days of the congress. Renowned specialists will present interesting cases with challenging findings, either pitfalls and/or artefacts to improve your skillness.

34

S C I E N T I F I C P R O G R A M M EP

RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G

1 Friday, October 23, 09:00 – 10:30 Quantification and Standardisation in Clinical and Preclinical Molecular ImagingTranslational Molecular Imaging and Therapy + Physics Committee / EARL

2 Friday, October 23, 10:40 – 11:40 The Uncomfortable Truth – Are Nuclear Medicine PhysiciansViewed as Second Class Doctors Compared to Radiologists?

3 Saturday, October 24, 09:00 – 10:30 A Practical Guide to MR when Reading PET/MR

4 Saturday, October 24, 10:40 – 11:40 The Intellectual and Emotional Journey to Radiology and Nuclear Equality

5 Friday, October 30, 09:00 – 10:30PET/CT Guided BiopsyOncology & Theranostics Committee

6 Friday, October 30, 10:40 – 12:10 Difficult Cases in Cardiac ImagingCardiovascular Committee

7 Friday, October 30, 13:50 – 15:20Molecular Imaging in Thyroid NodulesThyroid Committee

TEACHINGSESSIONSThis year’s seven teaching sessions will span over three days of the congress. Specialists will present interesting cases and will guide you from patients’ history through diagnosis to treatment options.

EANMRESEARCHLTD (EARL)

Allowing sites to benefit from state-of-the-art PET/CT technology while still ensuring

harmonized scanners performance,

UNIQUE 89Zr PET/CT ACCREDITATIONBased on and derived from the procedures performed for the 18F-FDG PET/CT accreditation which is a prerequisite for

89Zr accreditation

18F STANDARD 2 ACCREDITATION,

EARL is a 100% subsidiary of the EANM, which aims to enhance the quality of nuclear medicine practice for the benefit of public health.

earl.eanm.org

EARL RELEASED


3736


RO

GR

AM

ME

OV

ER

VI

EW

| O

CT

OB

ER

22

–3

0,

20

20

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


CUTTING EDGESCIENCE TRACK

M2MTRACK

The Cutting Edge Science Track (formerly known as the International Symposium on Dosimetry and Molecular Radiotherapy) will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine.

M2M – The 7th “From Molecule to Man” Track, covering translational developments in Imaging and Therapy will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine.

The International Symposium on Dosimetry and Molecular Radiotherapy (Do.MoRe) has taken place during the Annual Congress of the European Association of Nuclear Medicine for five consecutive years. It resulted from a series of interesting and important radiopharmaceutical and dosimetry symposia held from 1970 onwards and then continued at the 2004 EANM Congress and the 2009 SNM Congress. These symposia were formerly known as ISTARD (the International Symposium on Targeted Radiotherapy and Radiopharmaceutical Dosimetry). Since 2015, the symposia have been organised annually in parallel with the EANM Congress and the name was changed to Do.MoRe in order to emphasise the importance of dosimetry.

This year, it was decided together with the chairs of the committees involved to reorganize this separate track within the EANM Congress. The aim of this reorganization is to bring together all of the disciplines concerned with physics, dosimetry and radiobiology and to provide attendees with the most cutting edge innovations in these fields. Medical physics is a complex specialty which covers a broad range of areas ranging from the development of new detectors/imaging equipment to image reconstruction and quantification, dosimetry, tracer kinetics, radiobiology and radiation protection. Today’s new challenges include the integration of Artificial

Intelligence (AI) into most of these technical areas as well as its eventual implementation in clinical practice. Therefore, we decided to rename this track and give priority to the presentation of the most innovative aspects of all of these disciplines. In addition, one major objective is to enhance the interaction between all of these disciplines given their prominent role within the field of nuclear medicine by promoting a deeper interdisciplinary scientific discussion. Consequently, there will be more featured sessions which combine guest speakers and paper presentations and which involve clinical contributors.

The Cutting Edge Science Track will start with many featured sessions (combining guest speakers and paper presentations) throughout the main congress days and an outstanding plenary session concerning “Total Body PET”. In addition, some mid-congress symposia, namely with “Artificial Intelligence in Image Acquisition, Reconstruction and Processing”, “Lutetium Therapy”, and “Improved insights on Radiobiology” have been planned.

The EANM Committees of Dosimetry, Radiation Protection, and Physics will coordinate the scientific programme for the meeting jointly with the support of the Congress Chair.

We are looking forward to welcoming you to EANM’20. Be part of it!

Mark Konijnenberg, EANM Dosimetry CommitteeSøren Holm, EANM Radiation Protection CommitteeDimitris Visvikis, EANM Physics Committee

Fijs van Leeuwen, EANM Translational Molecular Imaging & Therapy CommitteeMarianne Patt, EANM Radiopharmacy CommitteeJohnny Vercouillie, EANM Drug Development Committee

The 7th M2M Track will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine.

Since 2014, the M2M sessions have constituted one of the main pillars in the programme of the annual EANM Congress. With the M2M track the EANM aims to actively stimulate multidisciplinary interplay between the various scientific disciplines concerned with molecular/nuclear imaging and therapy. By providing a platform for a wide range of scientific and medical aspects, M2M sessions have succeeded in attracting scientists (e.g. radiochemists, physisists and biologists), industry representatives and clinicians alike. With that, a successful stepping stone for translational science has been established.

The M2M track comprises a series of plenary lectures, CME sessions, symposia and focused scientific sessions, all of which have the aim of connecting fundamental research with unmet medical needs and vice versa.

The EANM Committees for Translational Molecular Imaging and Therapy, Drug Development and Radiopharmacy jointly coordinate the scientific programme of the M2M track, while the EANM Executive Office handles organisational matters.

We hope you will enjoy the sessions of the M2M Track 2020!

3938

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


T E C H N O L O G I S T S ‘ P R O G R A M M ET E C H N O L O G I S T S ‘ P R O G R A M M E

Dear colleagues and friends,On behalf of the European Association of Nuclear Medicine Technologist Committee, I kindly invite you to join us at the 33rd Annual Congress of the EANM.

This year, the EANM congress will once again provide a full program dedicated to technologists. The focus will be on topics that are important for current practice in the nuclear medicine field, a sector in which scientific and technological advancements have been great. A wide range of subjects will be covered during the Congress. These will include quality control and calibration of instrumentation for imaging and dosimetry, updates in pediatric and neuroendocrine tumor imaging and topics such as departmental organization and advanced competencies.

As in previous years, the chosen topics will be addressed in seven Continuous Technologist Education (CTE) sessions and three mini-courses (MC), during which specialists will share their expertise and knowledge with the audience.

We are very proud to announce that one talk as part of the “Total Body PET” plenary on Thursday will focus on “Challenges for Technologists”.

Another new feature at this year’s edition will be the Mid-Congress Symposium for Technologists. The “Introduction to Dosimetry“ session will be a full-day symposium.

Owing to its visibility and the number of attendees, the EANM Annual Congress offers an excellent opportunity to share original research and clinical work, and the EANM-TC will be accepting abstracts from nuclear medicine technologists and related clinical scientists. To provide space for participants to present the results of their work, three oral presentation sessions and two e-poster presentation sessions will take place during the congress. As in recent years, we expect that these sessions will be of very high quality and offer a useful means to promote and share work. As an additional motivating factor, an award will be given to the best three oral presentations as well as the best e-poster presentation.

With my best regards,Andrea Santos Chair, EANM Technologist Committee

LETTER OFI N V I TAT I O Nby the Chair of the Technologist Committee

Andrea SantosChair, EANM Technologist Committee

4140

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


T E C H N O L O G I S T S ‘ P R O G R A M M ET E C H N O L O G I S T S ‘ P R O G R A M M E

TECHNOLOGISTS’TRACK

1 Thursday, October 22, 13:30 – 15:00 Tech Guide Launch » 08:00 – 08:10 Opening Technologist Track » 08:10 – 09:30 Technologist Committee

2 Thursday, October 22, 16:35 – 18:05 Update in Paediatric ImagingTechnologist + Paediatrics Committee

3 Saturday, October 24, 09:00 – 10:30 Calibration for Instrumentation for DosimetryTechnologist + Dosimetry Committee

4 Saturday, October 24, 10:40 – 12:10 NET Imaging and TherapyTechnologist Committee

13 Wednesday, October 28, 09:00 – 16:00 Mid-Congress Symposium for Technologists – Introduction to DosimetryTechnologist + Dosimetry + Physics Committee

1 Friday, October 23, 09:00 – 09:50 New Developments in Cardiac Imaging InstrumentationTechnologist Committee

2 Friday, October 23, 10:00 – 10:50 Advanced Practice in Hybrid Nuclear MedicineTechnologist Committee

3 Friday, October 23, 11:00 – 11:50 Alpha Emitters in TherapyTechnologist Committee

In addition to the CTE Sessions the Technologist’s Track includes 3 Mini Courses:

Mid-Congress Symposium

CTE Sessions

The Technologist Committee places a massive effort into delivering the most up-to date and highest quality educational initiatives. All sessions of this track are aimed specifically at the technologists’ audience.

5 Friday, October 30, 09:00 – 10:30Departmental OrganisationTechnologist Committee

6 Friday, October 30, 10:40 – 12:10Advanced CompetenciesTechnologist Committee

7 Friday, October 30, 13:50 – 15:20Quality Control of Imaging InstrumentationTechnologist Committee

4342

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0


e-POSTER AREA + O N D E MA N D S E S S I O N S

S C I E N T I F I C P R O G R A M M E

e-Poster Presentation SessionsAll accepted e-Posters can be viewed in the digital e-Posters Area. For any additional questions, the e-Posters submitters can be contacted via email through the e-Poster Area System.

On demand sessionsAll passed session can be viewed at any time one demand throughout the whole congress. Please be aware, that CME credits can only be collected for live streamed sessions.

45

PR

OG

RA

MM

E O

VE

RV

IE

W |

OC

TO

BE

R 2

2 –

30

, 2

02

0

E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G

E X H I B I T I O N

Developing Targeted Radionuclide Therapies in Precision Oncology.

www.itm.ag

PRECISELY FOR ME.

Dedicated to giving cancer patients better answers than “maybe”.

VISIT OUR

SATELLITE SYMPOSIUM

“Challenges and Innovative

Approaches in the

Management of Osteoblastic

Metastatic Disease.”

October 23, 2020, 16:55 – 18:25 (CET), Channel 10 at Virtual EANM 2020

INDUSTRY E X H I B I T I O NThe industry exhibition will be held virtually and all participants will have access throughout all congress days.You will have the chance to interactively get in touch with the companies.

The industry exhibition is available at any time on October 22-30, 2020


R E G I S T R AT I O NR E G I S T R AT I O N

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

G

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

G

Registration Fees in Euro (excl. VAT)

EANM Member* 140,-

Non-Member 280,-

EANM Junior Member* 1) 80,-

Junior Non-Member 1) 160,-

EANM Nurse/Technologist Member* 2) 45,-

Nurse/Technologist Non-Member 2) 95,-

EANM Associate Member* 140,-

Associate Non-Member 280,-

Student 3) 20,–

Mid-Congress Symposium ** 90,–

*Only members who have paid the full amount of their membership fee by May 31 of the respective year, will benefit from the reduced „Member“ registration fee for the Annual Congress of the EANM.

** reduced price for Nurse/Technologists, Students and Juniors

1) Physician or other scientist in training, up to the age of 38 (maximum age on November 1, 2020). For Junior Non-Members: confirmation letter (in English) incl. signature of Head of Department and copy of passport showing date of birth are indispensable for proof of status.

2) Nurse, healthcare technologist or laboratory technologist, being employed in a respective current professional occupation. Confirmation letter (in English) incl. signature of Head of Department is indispensable for proof of status.

3) Student without any academic degree, up to the age of 26 (maximum age on November 1, 2020), even if a degree has been achieved in a completely different field and/or has no relevance to the current professional occupation. Confirmation letter (in English) incl. signature of Head of Department and copy of passport showing date of birth are indispensable for proof of status. Students already holding an academic degree (and not older than 38 years of age on November 1, 2020) must register as Juniors!

To register for EANM’ 20 please use our online registration platform: eanm20.eanm.org

REGISTRATIONFEES

https://eanm20.eanm.org/registration-2/registration-fees/


G E N E R A L I N F O R M AT I O NG E N E R A L I N F O R M AT I O N

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

G

EA

NM

’20

WO

RL

D L

EA

DIN

G M

EE

TIN

G

GENERALI N F O R MAT I O NCALL FOR ABSTRACTSThe deadline for abstract submission is April 25, 2020.Authors will be notified about the acceptance of abstracts by email on June 26, 2020.

CERTIFICATE OF ATTENDANCE

Certificates of Attendance will be available in your myEANM area after the congress.

CONGRESS CLOSING

The Congress Closing will be broadcasted right after the Highlights Lecture on October 30, 2020. All registered delegates can join online.

CME CREDITES & CERTIFICATES

To acquire CME credits, an evaluation form must also be completed for each session attended.

The EANM’20 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 31 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

The EANM’20 – Mid-Congress Symposia have been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

CONGRESS APP

No congress app will be provided. All registered participants have access to the virtual online platform via their myEANM Area login.

E-POSTER AREA

As every year, the e-Poster Area gives you the possibility to read all uploaded e-Posters of EANM’20. You can search for authors, topics and keywords.

LANGUAGE

The congress language is English. No simultaneous translation will be provided.

EANM OFFICE

The congress office will be available during all congress days via email and phone. Further details will be published soon.

DISCLAIMERIn the event the congress has to be cancelled by the organisers because of force majeure, the registration fee, and any other payments for services ordered through the registration process will be partially refunded or forfeited, which is subject to the commitments of the congress organisers at that time.

EANM EXECUTIVE OFFICE

Schmalzhofgasse 261060 Vienna, AustriaPhone: +43 1 890 44 27Fax: +43 1 890 44 27-9Email: [email protected]: www.eanm.org

EANM MEMBERS’ ASSEMBLY

The Members’ Assembly will be held virtually onSaturday, October 17, 2020 from 16:30-18:30.

Please note: Only EANM members in good standing (having paid their membership dues for the year 2020) are eligible to attend the Members’ Assembly.

INTERNATIONAL MEETINGS ANDANNOUNCEMENT SECTION

Visit the International Meetings and Announcement Board to get information on upcoming events in Nuclear Medicine and more.

VIRTUAL CONGRESS OPENING & WELCOME HAPPY HOUR

All registered delegates are invited to attend virtually the

Virtual Congress Opening & Welcome Happy HourThursday, October 22, 2020 – 18:00-20:00

VIRTUAL INDUSTRY EXHIBITION

Inside our fully virtual conference halls, the user can enter a real-life animated exhibition hall while being able to move around and navigate interactively.Visitors will be able to communicate with booth staff via state-of-the-art chat tools, see models of the newest products, participate in raffles and quizzes and even find dedicated job offerings.All Members of the EANM Nuclear Medicine Community can participate without closing times 24/7 to this active meeting and job-market tool completely free of charge.

Special thanks to the EANM Committees and the ESMIT Working Groups for their continuing support.

European School of Multimodality Imaging and Therapy

Course Programme2021

Please note that the information given above is subject to change.For regular updates, please visit the EANM website or

subscribe to the ESMIT vNewsletter.

Acknowledgement

eanm.org/esmit

The ESMIT leadership likes to thank all contributors of this initiative. Special thanks to the EANM Committees and the ESMIT Project Groups for their continuing support.

Dosimetry Practical Implementation of Clinical Dosimetry in NM Therapy Feb 2021

Oncology Therapy Assessment Mar 2021

Physics Advanced Features of Quantification Apr 2021

Neurology Quantification in Neurology Apr 2021

Bone & Joint Post-Operative Skeleton Jun 2021

Oncology Prostate Cancer (advanced) Sep 2021

Thyroid Management of Thyroid Cancer (advanced) Nov 2021

Tba Theranostics Dec 2021

Speakers: Ian Armstrong, John Dickson, Stephan Nekolla, Dimitris Visvikis

Moderator: Michel Koole

Nuclear Imaging Technology: Where we came from, where we are and

where we are heading

ESMIT Live Webinar series - to be continued!

Speakers: Mark Lubberink, Roberto Sciagra

Moderator: Christoph Rischpler

PET MPI: Tracers, Equipment, Protocols, Flow Quantification, Viability

Plac

e:Pl

ace:

PHYS

ICS

CARD

IOLO

GY

Stay tuned for more ESMIT Live Webinars coming up in 2021!

For more information visit the ESMIT Booth of EANM’20

O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L52

U S E F U L A D D R E S S E S

SCIENTIFIC PROGRAMME EANM Executive OfficeMs. Susanne KoebeSchmalzhofgasse 26/5, 1060 Vienna, AustriaPhone: +43 1 890 44 27 Fax: +43 1 890 44 27-9Email: [email protected]: eanm20.eanm.org

INDUSTRY EXHIBITION EANM Executive OfficeMr. Andreas Felser (Congress Manager)Mrs. Silvia Zippelius (Exhibition & Sponsoring)Schmalzhofgasse 26/5, 1060 Vienna, AustriaPhone: +43 1 890 44 27 Fax: +43 1 890 44 27-9Email: [email protected]: eanm20.eanm.org

REGISTRATION EANM Executive OfficeMs. Petra NeubauerSchmalzhofgasse 26/5, 1060 Vienna, AustriaPhone: +43 1 890 44 27 Fax: +43 1 890 44 27-9Email: [email protected]: eanm20.eanm.org

USEFULCO N TAC TS

mailto:office%40eanm.org?subject=

http://eanm20.eanm.org

mailto:office%40eanm.org?subject=


mailto:registration%40eanm.org?subject=


Documents

THURSDAY | October 22, 2020 · e-Poster Presentation Session 1 Oncology & Theranostics PET Diagnostics - Part 1 13:30-15:00 15:00 - 15:10 15:00 - 15:10 15:10 - 16:25 201 Plenary 1